$VSEE News

VSee Health Shareholder Letter

VSee Health Poised for Growth

VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

VSEE Vertically Integrated Healthcare Commerce Platform

Vsee Health Enters Into Non-Binding LOI For Proposed Acquisition Of Healthcare Technology And Operating Assets With $35M Plus Run Rate And $7M EBITDA

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

VSee Health Outlines AI-Enabled Enterprise Infrastructure Strategy for Hospital Operations

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

VSee Health CEO Issues Shareholder Letter; Expects That Its iDoc Telehealth Business Can Achieve Profitability Over Next 12 Months

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership

VSee Health Q1 EPS $(0.05) Up From $(0.24) YoY, Sales $3.160M Down From $3.321M YoY

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet

VSee Health Q4 EPS $(0.31), Sales $3.926M Up From $3.859M YoY

VSee Health Q4 EPS $(0.31), Sales $3.926M Up From $3.859M YoY

VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026